BIOREM Inc.
BRM.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 25.90K | 122.00K | 1.61M | 246.20K | 255.20K |
| Total Depreciation and Amortization | 93.70K | 100.00K | 135.40K | 54.70K | 54.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 50.50K | -419.60K | 617.80K | 131.40K | 129.60K |
| Change in Net Operating Assets | 3.10M | -1.01M | -91.50K | -1.82M | 2.66M |
| Cash from Operations | 3.27M | -1.21M | 2.27M | -1.39M | 3.10M |
| Capital Expenditure | -63.30K | -3.70K | 0.00 | -2.70K | -269.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -63.30K | -3.70K | 0.00 | -2.70K | -269.30K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -206.10K | -129.60K | -201.70K | -170.00K | -227.70K |
| Issuance of Common Stock | -- | 156.90K | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -143.60K | 19.50K | -147.90K | -124.30K | -168.90K |
| Foreign Exchange rate Adjustments | -7.50K | -281.60K | 350.10K | 53.60K | 17.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.06M | -1.47M | 2.47M | -1.46M | 2.68M |